BWP
ABBV icon

Baldwin Wealth Partners’s AbbVie ABBV Stock Holding History

Baldwin Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
6,976
+463
+7% +$99.6K 0.11% 92
2026
Q1 		$1.42M Sell
6,513
-1,136
-15% -$252K 0.1% 95
2025
Q4 		$1.75M Sell
7,649
-266
-3% -$60.6K 0.11% 90
2025
Q3 		$1.83M Buy
7,915
+138
+2% +$28.1K 0.12% 86
2025
Q2 		$1.44M Buy
7,777
+19
+0.2% +$3.53K 0.1% 89
2025
Q1 		$1.63M Sell
7,758
-194
-2% -$37.7K 0.11% 87
2024
Q4 		$1.41M Sell
7,952
-2,008
-20% -$369K 0.1% 94
2024
Q3 		$1.97M Buy
9,960
+3,666
+58% +$684K 0.13% 86
2024
Q2 		$1.08M Sell
6,294
-30
-0.5% -$4.97K 0.08% 99
2024
Q1 		$1.15M Sell
6,324
-445
-7% -$76.7K 0.09% 104
2023
Q4 		$1.05M Sell
6,769
-817
-11% -$119K 0.08% 105
2023
Q3 		$1.13M Sell
7,586
-6,868
-48% -$1.01M 0.1% 103
2023
Q2 		$1.95M Hold
14,454
– – 0.16% 89
2023
Q1 		$2.3M Hold
14,454
– – 0.2% 88
2022
Q4 		$2.34M Buy
14,454
+2,654
+22% +$407K 0.21% 89
2022
Q3 		$1.58M Sell
11,800
-1,055
-8% -$151K 0.22% 58
2022
Q2 		$1.97M Hold
12,855
– – 0.26% 55
2022
Q1 		$2.08M Buy
12,855
+7,800
+154% +$1.13M 0.22% 60
2021
Q4 		$684K Buy
5,055
+150
+3% +$17.7K 0.07% 97
2021
Q3 		$529K Hold
4,905
– – 0.06% 107
2021
Q2 		$552K Hold
4,905
– – 0.06% 109
2021
Q1 		$531K Hold
4,905
– – 0.06% 102
2020
Q4 		$526K Sell
4,905
-801
-14% -$77K 0.07% 98
2020
Q3 		$500K Sell
5,706
-35
-0.6% -$3.29K 0.07% 100
2020
Q2 		$564K Hold
5,741
– – 0.08% 93
2020
Q1 		$437K Hold
5,741
– – 0.08% 98
2019
Q4 		$508K Buy
5,741
+335
+6% +$27.8K 0.07% 109
2019
Q3 		$409K Hold
5,406
– – 0.06% 119
2019
Q2 		$393K Sell
5,406
-150
-3% -$11.8K 0.06% 141
2019
Q1 		$448K Sell
5,556
-39
-0.7% -$3.19K 0.07% 134
2018
Q4 		$516K Buy
5,595
+689
+14% +$60.6K 0.09% 113
2018
Q3 		$464K Hold
4,906
– – 0.07% 134
2018
Q2 		$455K Buy
4,906
+150
+3% +$14.6K 0.07% 131
2018
Q1 		$450K Sell
4,756
-559
-11% -$61.4K 0.07% 130
2017
Q4 		$514K Sell
5,315
-6
-0.1% -$565 0.08% 123
2017
Q3 		$473K Buy
5,321
+100
+2% +$7.61K 0.08% 126
2017
Q2 		$379K Sell
5,221
-2,799
-35% -$188K 0.06% 144
2017
Q1 		$523K Sell
8,020
-551
-6% -$34.6K 0.09% 122
2016
Q4 		$537K Hold
8,571
– – 0.1% 114
2016
Q3 		$541K Buy
8,571
+1
+0% +$65 0.1% 119
2016
Q2 		$531K Buy
8,570
+15
+0.2% +$914 0.11% 111
2016
Q1 		$489K Buy
8,555
+3,520
+70% +$196K 0.09% 149
2015
Q4 		$298K Buy
5,035
+346
+7% +$19.9K 0.05% 184
2015
Q3 		$255K Buy
4,689
+1,600
+52% +$104K 0.04% 199
2015
Q2 		$208K Sell
3,089
-6,030
-66% -$394K 0.03% 222
2015
Q1 		$534K Sell
9,119
-132,086
-94% -$7.98M 0.08% 165
2014
Q4 		$9.24M Buy
141,205
+5,104
+4% +$322K 1.34% 26
2014
Q3 		$7.86M Buy
136,101
+6,655
+5% +$369K 1.12% 31
2014
Q2 		$7.31M Buy
129,446
+3,425
+3% +$180K 1.08% 31
2014
Q1 		$6.48M Buy
126,021
+30,390
+32% +$1.54M 1.04% 34
2013
Q4 		$5.05M Buy
95,631
+780
+0.8% +$38.3K 0.81% 42
2013
Q3 		$4.24M Buy
94,851
+105
+0.1% +$4.65K 0.78% 46
2013
Q2 		$3.92M Buy
+94,746
New +$4.14M 0.77% 45

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Baldwin Wealth Partners's ABBV Position: Q2 2026 in Review

Baldwin Wealth Partners increased its AbbVie (ABBV) stake by 7.1% in Q2 2026, buying an estimated $99.6K and bringing the position to 6,976 shares worth $1.76M. The position accounts for 0.11% of the portfolio, ranked #92.

Baldwin Wealth Partners first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.24M in Q4 2014. 2,035 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Baldwin Wealth Partners held 6,976 shares of AbbVie worth $1.76M as of Q2 2026.
  • Baldwin Wealth Partners bought 463 AbbVie shares in Q2 2026, an estimated $99.6K.
  • AbbVie made up 0.11% of Baldwin Wealth Partners's portfolio in Q2 2026, its #92 holding.
  • Baldwin Wealth Partners first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Baldwin Wealth Partners's AbbVie position peaked at $9.24M in Q4 2014.
  • 2,035 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.